CORMORANT ASSET MANAGEMENT, LP – Axsome Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$0
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+16.50%
quarter
Axsome Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -100.00% | -205K shares | -7.85M | $44.62 | 0 |
Q2 2022 | share | Increase | 0.00% | 205K shares | 7.85M | $38.3 | 205K |
Q2 2021 | share | Decrease | -100.00% | -200K shares | -11.32M | $67.46 | 0 |
Q1 2021 | share | 0.00% | 0 shares | -4.97M | $56.62 | 200K | |
Q4 2020 | share | Decrease | -20.00% | -50K shares | -1.51M | $81.47 | 200K |
Q3 2020 | share | Decrease | -28.57% | -100K shares | -10.98M | $71.25 | 250K |
Q2 2020 | share | Decrease | -30.00% | -150K shares | -617K | $82.28 | 350K |
Q1 2020 | share | Decrease | -16.67% | -100K shares | -32.60M | $58.83 | 500K |
Q4 2019 | share | Increase | 0.00% | 600K shares | 62.01M | $103.36 | 600K |